Provided by Tiger Fintech (Singapore) Pte. Ltd.

XOMA Corp

21.18
+0.65003.17%
Post-market: 21.180.00000.00%16:05 EDT
Volume:14.85K
Turnover:312.79K
Market Cap:253.71M
PE:-12.84
High:21.58
Open:20.64
Low:20.59
Close:20.53
Loading ...

Company Profile

Company Name:
XOMA Corp
Exchange:
NASDAQ
Establishment Date:
1981
Employees:
13
Office Location:
2200 Powell Street,Suite 310,Emeryville,California,United States
Zip Code:
94608
Fax:
- -
Introduction:
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Directors

Name
Position
John Varian
Chief Executive Officer and Director
W. Denman Van Ness
Chairman of the Board
Patrick J. Scannon
Executive Vice President, Chief Scientific Officer and Director
Jack L. Wyszomierski
Director
Joseph M. Limber
Director
Peter Barton Hutt
Director
Timothy P. Walbert
Director
William K. Bowes, Jr.
Director

Shareholders

Name
Position
John Varian
Chief Executive Officer and Director
James Neal
Senior Vice President and Chief Operating Officer
Fred Kurland
Vice President, Finance, Chief Financial Officer and Secretary
Paul D. Rubin
Senior Vice President, Research and Development and Chief Medical Officer
Tom Burns
Vice President, Finance and Chief Financial Officer
Chris Wells
Vice President, Human Resources and Information Technology
Patrick J. Scannon
Executive Vice President, Chief Scientific Officer and Director
Thomas Klein
Vice President, Chief Commercial Officer